Oruka Therapeutics, Inc. · NASDAQ:ORKA
Agarwal Arjun sold 10,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Aug 13, 2026 · Filed Aug 14, 2026
On Aug 13, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 10,000 Oruka Therapeutics, Inc. shares at an average US$106.66 for US$1.07M under a trading plan, leaving 15,312 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$106.66 average (US$104.67 to US$108.46)
- Value
- US$1.07M
- Holding after
- 15,312 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Senior Vice President, Finance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | Option exercise | 8,542 | US$12.50 | 23,854 | Direct |
| Aug 13, 2026 | Common Stock | Option exercise | 1,458 | US$34.39 | 25,312 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,100 | US$104.67 | 23,212 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,132 | US$105.57 | 21,080 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 1,268 | US$106.63 | 19,812 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,142 | US$107.71 | 17,670 | Direct |
| Aug 13, 2026 | Common Stock | Sale | 2,358 | US$108.46 | 15,312 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Agarwal Arjun
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 15, 2026
- Form 4 · Agarwal Arjun · Jul 13, 2026
- Form 4 · Agarwal Arjun · Jun 22, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026